Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
49 studies found for:    Open Studies | "Abortion, Spontaneous"
Show Display Options
Rank Status Study
1 Recruiting Interleukin-10 Promoter-1082A/G Polymorphism and Idiopathic Recurrent Miscarriage Risk
Condition: Abortion, Spontaneous
Intervention: Genetic: IL-10 polymorphism
2 Not yet recruiting Misoprostol 400 µg Versus 200 µg for Cervical Ripening in 1st Trimester Miscarriage
Condition: Miscarriage, Incomplete
Interventions: Drug: Misoprostol 400 µg;   Drug: Misoprostol 200 µg
3 Recruiting Knowledge, Attitude and Practices of Flemish Midwifes Regarding Spontaneous Abortion
Condition: Spontaneous Abortion
Intervention: Other: survey
4 Recruiting Intralipid for Recurrent Miscarriage
Conditions: Abortion, Spontaneous;   Abortion, Habitual
Intervention: Drug: Intralipid
5 Not yet recruiting Use of Cyclosporin A for the Treatment of Recurrent Miscarriage
Condition: Miscarriage, Recurrent
Interventions: Drug: Cyclosporin A;   Drug: Dydrogesterone
6 Recruiting Could Colour Dopper Improve the Diagnosis of Retained Placental Fragments After Second Trimester Miscarriage ?
Condition: Miscarriage
Intervention: Device: ultrasoungraphy
7 Recruiting Evaluation of the Safety and Efficacy of GB-0998 in Unexplained Primary Recurrent Miscarriage
Condition: Recurrent Miscarriage
Interventions: Drug: GB-0998;   Drug: Placebo
8 Recruiting Sim (Scratch in Miscarriage) Study
Condition: Recurrent Miscarriage
Interventions: Other: Endometrial scratch;   Other: Touching the cervix
9 Recruiting Vaginal Progesterone for Treatment of Threatened Miscarriage
Condition: Threatened Miscarriage
Intervention: Drug: Vaginal Progesteron
10 Recruiting Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial
Conditions: Miscarriage;   Preterm Birth
Interventions: Drug: Progesterone;   Drug: Placebo
11 Recruiting EmbryoGen/ Blastgen for Couples With Implantation Problems or Previous Miscarriage
Conditions: Recurrent Miscarriage;   Infertility
Interventions: Device: EmbryoGen/ BlastGen media;   Device: Standard Cook sequential media
12 Not yet recruiting Chinese Herbal Medicine and Micronized Progesterone for Threatened Miscarriage RCT
Condition: Threatened Miscarriage
Interventions: Drug: Chinese herbal medicine granules;   Drug: Micronized progesterone;   Drug: Chinese herbal medicine granules placebo;   Drug: Micronized progesterone placebo
13 Recruiting Description of the Uterine Cavity in Patients With Recurrent Miscarriages
Conditions: Recurrent Miscarriages;   Habitual Abortions
Intervention: Other: Office hysteroscopy
14 Recruiting Letrozole Pretreatment With Misoprostol for Second-Trimester Medical Abortion
Condition: Miscarriage
Interventions: Drug: Letrozole;   Drug: Placebo;   Drug: Misoprostol
15 Recruiting Comparative Effectiveness of Pregnancy Failure Management Regimens
Condition: Spontaneous Abortion
Interventions: Drug: Misoprostol;   Drug: Mifepristone
16 Recruiting Effectiveness of Hysteroscopy in the Treatment of Intrauterine Trophoblastic Retentions
Condition: Incomplete Miscarriage
Interventions: Procedure: Hysteroscopy;   Procedure: Curettage
17 Recruiting Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened Miscarriage
Condition: Pregnancy
Interventions: Drug: Dydrogesterone;   Drug: Placebo
18 Recruiting Effect of Trophectoderm Biopsy for Sex Selection on the Pregnancy and Miscarriage Rates of Women Undergoing IVF/ICSI
Condition: Assisted Reproduction
Intervention: Procedure: Trophectoderm embryo biopsy
19 Recruiting Fetal Viability Estimation in Egypt
Conditions: Premature Birth;   Miscarriage
Intervention:
20 Not yet recruiting Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration
Conditions: Other Abortion;   Spontaneous Abortion
Interventions: Drug: Gabapentin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.